FDA Clearance Tracker · K240686
Healgen Accurate Urine Drug Screen Dip Card; Healgen Accurate Home Urine Drug Test Dip Card
Last checked: Nov 19, 2026Latest source record: Apr 12, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Apr 12, 2024
Substantially Equivalent
Time to decision
31 days
Received Mar 12, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K240686
- Device name
- Healgen Accurate Urine Drug Screen Dip Card; Healgen Accurate Home Urine Drug Test Dip Card
- Applicant
- Healgen Scientific,, LLC
- Applicant location
- Houston, TX
- Received
- Mar 12, 2024
- Decided
- Apr 12, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Test, Opiates, Over The Counter (NGL)
- Device class
- Class II
- Regulation
- 21 CFR 862.3650
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NGL. The earliest in FDA's data is K082898, decided Dec 19, 2008.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K240686
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Healgen Scientific,, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260095 · Decided Apr 13, 2026 · 90 days after receipt
Device type: Over-The-Counter Covid-19 Antigen Test (QYT) · Laboratory Medicine & Pathology
K253705 · Decided Mar 16, 2026 · 112 days after receipt
Device type: Thin Layer Chromatography, Methamphetamine (DJC) · Laboratory Medicine & Pathology
K252523 · Decided Feb 12, 2026 · 185 days after receipt
Device type: Test, Cannabinoid, Over The Counter (NFW) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.